Cargando…

The Clinical Impact of Tumor Grade Heterogeneity in Non-muscle-invasive Urothelial Carcinoma of the Bladder

OBJECTIVE: This study aimed to determine the oncological outcomes of mixed-grade tumors by comparing them with pure low-grade and high-grade tumors. METHODS: We retrospectively reviewed the medical records of patients with primary non-muscle-invasive bladder cancer. Patients were categorized into th...

Descripción completa

Detalles Bibliográficos
Autores principales:	CULPAN, Meftun, KESER, Ferhat, IPLIKCI, Ayberk, KIR, Gozde, ATIS, Gokhan, YILDIRIM, Asif
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694165/ https://www.ncbi.nlm.nih.gov/pubmed/34937341 http://dx.doi.org/10.4274/MMJ.galenos.2021.48447

Ejemplares similares

The prognostic impact of tumor necrosis in non-muscle invasive bladder cancer
por: Culpan, Meftun, et al.
Publicado: (2022)

The Impact of Histological Variants on Oncological Outcomes in Patients with Muscle Invasive Bladder Cancer Treated with Radical Cystectomy
por: Efiloğlu, Özgür, et al.
Publicado: (2023)

The Role of Preoperative Urinalysis in Predicting Postoperative Infection After Retrograde Intrarenal Surgery in Patients with Sterile Urine Culture
por: Kazan, Ozgur, et al.
Publicado: (2022)

The clinical impact of androgen deprivation therapy on SARS-CoV-2 infection rates and disease severity
por: Kazan, Özgür, et al.
Publicado: (2021)

The Clinical Impact of Physical Activity on the Diagnosis of Prostate Cancer and Postprostatectomy Functional Outcomes in the Elderly
por: Kazan, Ozgur, et al.
Publicado: (2023)

Biopsy with Ureterorenoscopy Before Radical Nephroureterectomy is Associated with Increased Intravesical Recurrence in Urothelial Cancer Located in the Kidney
por: Culpan, Meftun, et al.
Publicado: (2022)

Can intervals in extracorporeal shock wave lithotripsy sessions affect success in the treatment of upper ureteral stones?
por: Turan, Turgay, et al.
Publicado: (2018)

Mini-percutaneous nephrolithotomy in a child with multiple urogenital anomalies and a solitary duplex kidney
por: Çakici, Mehmet Çaglar, et al.
Publicado: (2021)

Oncologic outcomes of postoperative adjuvant versus salvage radiotherapy in prostate cancer
por: Şendoğan, Furkan, et al.
Publicado: (2023)

Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder
por: Turan, Turgay, et al.
Publicado: (2018)

Prognostic Implications of Deep Muscle Invasion and High Grade for Bladder Urothelial Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2020)

Comparison of Biparametric and Multiparametric Prostate Magnetic Resonance Imaging in Predicting Oncologic Outcomes After Radical Prostatectomy
por: EFILOGLU, Ozgur, et al.
Publicado: (2022)

Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
por: Garczyk, Stefan, et al.
Publicado: (2022)

The Bladder Microbiome Is Associated with Epithelial–Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma
por: Li, Wei Tse, et al.
Publicado: (2021)

Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma
por: Basatac, Cem, et al.
Publicado: (2019)

Bioinformatic Identification of Potential Hub Genes in Muscle-Invasive Bladder Urothelial Carcinoma
por: Guo, Changgang, et al.
Publicado: (2020)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Muscle invasive urinary bladder urothelial carcinoma presenting with secondary nephrotic symptoms
por: Mizusawa, Hiroya, et al.
Publicado: (2021)

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
por: Renner, Alex, et al.
Publicado: (2021)

The clinical impact of the COVID-19 pandemic on daily urological practice: first 3-month multicenter results from İstanbul
por: ÇAKICI, Mehmet Çağlar, et al.
Publicado: (2021)

Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder
por: Jin, Subin, et al.
Publicado: (2017)

Intratumoral heterogeneity of surrogate molecular subtypes in urothelial carcinoma in situ of the urinary bladder: implications for prognostic stratification of high-risk non-muscle-invasive bladder cancer
por: Garczyk, Stefan, et al.
Publicado: (2021)

Gastrocnemius acrometastasis from muscle-invasive urothelial bladder carcinoma: A case report
por: Roslly, Mohd Zulkimi, et al.
Publicado: (2021)

Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans
por: Tsamouri, Maria Malvina, et al.
Publicado: (2021)

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
por: Kim, Hongsik, et al.
Publicado: (2023)

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
por: Sung, Hyun Hwan, et al.
Publicado: (2022)

Tumor heterogeneity in muscle-invasive bladder cancer
por: Kang, Ho Won, et al.
Publicado: (2020)

Grading Systems for Canine Urothelial Carcinoma of the Bladder: A Comparative Overview
por: Brambilla, Eleonora, et al.
Publicado: (2022)

Transcriptome Profiling of a Multiple Recurrent Muscle-Invasive Urothelial Carcinoma of the Bladder by Deep Sequencing
por: Zhang, Shufang, et al.
Publicado: (2014)

Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder
por: Massari, Francesco, et al.
Publicado: (2015)

Moderate or severe LUTS is associated with increased recurrence of non - muscle - invasive urothelial carcinoma of the bladder
por: Lunney, Austin, et al.
Publicado: (2019)

The Influence of Inverted Growth Pattern on Recurrence for Patients with Non-Invasive Low Grade Papillary Urothelial Carcinoma of Bladder
por: Arslankoz, Sehbal, et al.
Publicado: (2017)

Significance of Vascular Endothelial Growth Factor Expression in the Bladder Urothelial Carcinoma and Its Association with Tumor Grade and Invasiveness
por: Sadaf, Anika, et al.
Publicado: (2021)

Telomere instability in papillary bladder urothelial carcinomas: Comparison with grading and risk of recurrence
por: Mucciardi, Giuseppe, et al.
Publicado: (2014)

High-Grade Urothelial Carcinoma of Bladder Transforming to Micropapillary Variant on Follow-Up
por: Kumari, Nitu, et al.
Publicado: (2017)

Primary malignant melanoma of the bladder collides with high-grade non-invasive urothelial papillary carcinoma: A case report
por: Chen, Xiaodan, et al.
Publicado: (2022)

Plasmacytoid urothelial carcinoma of the bladder with extensive scrotal wall invasion
por: Wang, Yong Gang, et al.
Publicado: (2016)

Expression of Fibroblast Growth Factor Receptor 3 in the Recurrence of Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
por: Maeng, Young-Hee, et al.
Publicado: (2010)

Status of Her2 over expression in muscle invasive urothelial bladder carcinoma: Report of 21 cases
por: Mejri, Nesrine, et al.
Publicado: (2014)

Prognostic factors for conditional survival in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy
por: Kang, Minyong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_opnu13fim2ocn40ccatc25rca1